Aethlon Medical, Inc.
AEMD
$1.71
-$0.11-5.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.54% | -4.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.54% | -4.83% | |||
| Operating Income | 19.54% | 4.83% | |||
| Income Before Tax | 17.85% | 6.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.85% | 6.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.85% | 6.63% | |||
| EBIT | 19.54% | 4.83% | |||
| EBITDA | 20.01% | 4.92% | |||
| EPS Basic | 46.15% | 39.05% | |||
| Normalized Basic EPS | 47.09% | 37.97% | |||
| EPS Diluted | 46.15% | 39.05% | |||
| Normalized Diluted EPS | 47.09% | 37.97% | |||
| Average Basic Shares Outstanding | 52.54% | 53.22% | |||
| Average Diluted Shares Outstanding | 52.54% | 53.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||